Lung Cancer Treatment

Early Treatment with Lorlatinib Helps in Improving Lung Cancer Survival Rate

Lung Cancer Treatment
Non-small cell lung cancer accounts for 87% of all lung cancer cases and some 5% of NSCLC cases are ALK-positive. This implies that they have genetic [...]

Post-Surgical Lung Cancer Treatments

Lung Cancer Treatment
Surgery is the treatment option for patients with non-small cell lung cancer. It might be the best option as it provides high chances of curing the disease. [...]

Proton Therapy for Lung Cancer May Help Prevent Heart Disease

Lung Cancer
Proton therapy for lung cancer treatment is a reasonable treatment for patients whose cancer is limited to the chest. The physicians are able to deliver highly [...]

Moffitt Researchers Develop Tool to Predict Lung Cancer Treatment

Cancer Cell
Choosing the right therapy for non-small cell lung cancer patient is not always an easy decision. Biomarkers can change during the therapy, making that [...]

Health Benefits of Fennel for Lung Cancer Patients

Fennel-2
Lung Cancer is a serious health problem having no respect for age and sex and can affect any person at any interval of time. Various ayurvedic herbs help lung [...]

Korean Study Examined Three-Drug Combo to Reduce Lung Cancer Risk

Drug
The combined use of aspirin, statins and metformin is associated with reduced risk of lung cancer, according to a study published in the Journal of Thoracic [...]

New EarlyCDT-Lung Blood Test for Early Detection of Lung Cancer

Blood Test
Thanks to the pioneering new blood test, lung cancer could be detected earlier. This news comes as a fresh hope for lung cancer patients. The main reason [...]

Non-Smoking Lung Cancer Patients May Respond Differently to Treatment

Although smoking remains the main cause of lung cancer for most of the patients but there are other factors as well which may cause lung cancer. Non-smokers [...]

Ramucirumab Injection in Combination with Erlotinib Gets FDA Approval for NSCLC

Non-Small-Cell Lung Cancer (NSCLC)
The Food and Drug Administration (FDA) has approved a 10mg/mL solution for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) [...]

Alunbrig Gets FDA Approval for Frontline ALK-Positive Lung Cancer Patients

Non-Small-Cell Lung Cancer (NSCLC)
FDA has approved Alunbrig or Brigatinib for first-line treatment of patients with ALK-positive metastatic non-small cell lung cancer, as detected by [...]

FDA Approves Tabrecta, First Targeted Therapy for NSCLC

Non-Small-Cell Lung Cancer (NSCLC)
The FDA has approved Tabrecta, Novartis for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. NSCLC is the most [...]

Tackling Coronavirus during Lung Cancer Treatment

Lung Cancer Treatment & Covid-19
At the end of year 2019, a novel coronavirus was identified in Wuhan, a city in the Hubei Province of China. It spread rapidly and resulted in an increasing [...]

Yale Cancer Center Study Shows Long-Term Survival Benefits for Lung Cancer Patients

Lung Cancer
As per the global study led by Yale Cancer Center, a tiny amount of biomarker known as PD-L1 can predict long-term survival benefits from pembrolizumab. [...]

Obesity May Boost Effectiveness of Lung Cancer Treatment, According to Study

Obesity
The latest study in the field of lung cancer has revealed that an immune system-based treatment for lung cancer, worked better in people who were overweight in [...]